Open AccessPoint-Counterpoint: Have Targeted Agents Significantly Altered the Long-Term Outcome for Patients with Advanced Hepatocellular Carcinoma?
Author(s) -
Brande Victorian
Publication year - 2010
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000383061.74286.fc
Subject(s) - sorafenib , medicine , hepatocellular carcinoma , clinical endpoint , oncology , population , incidence (geometry) , cancer , clinical trial , physics , environmental health , optics